To facilitate the identification of new candidate phytochemicals agents for their use as inhibitors of breast and lung cancer by targeting the Epidermal Growth Factor Receptor Tyrosine Kinase Domain (EGFR-TKD). Here, EGFR is linked to lung cancer.